Score Overview
Explore the 2021 public Archive ranking →
Where Sensus Healthcare Inc has ranked, year by year
Not enough ranking history to display a chart
This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. SRTS does not have enough ranked years in the public Archive through 2021.
More recent Archive years are available with Membership. Coverage varies by company and measure.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-10-22 | $ 2.87 | — |
1 Year2025-10-22 | $ 3.22 | -10.87% |
5 Years2021-10-22 | $ 4.03 | -28.78% |
10 Years2016-10-21 | $ 6.35 | -54.80% |
| Period | Last Price2026-10-22 | 1 Year2025-10-22 | 5 Years2021-10-22 | 10 Years2016-10-21 |
|---|---|---|---|---|
| Price | $ 2.87 | $ 3.22 | $ 4.03 | $ 6.35 |
| Return | — | -10.87% | -28.78% | -54.80% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 22M | -$ 7M | $ 18M |
| 2025 | $ 27M | -$ 7M | $ 22M |
| 2024 | $ 41M | $ 6M | $ 22M |
| 2023 | $ 24M | $ 485K | $ 23M |
| 2022 | $ 44M | $ 24M | $ 25M |
| 2021 | $ 27M | $ 4M | $ 14M |
| 2020 | $ 9M | -$ 6M | $ 14M |
| 2019 | $ 27M | -$ 1M | $ 15M |
| 2018 | $ 26M | -$ 2M | $ 15M |
| 2017 | $ 20M | -$ 3M | $ 11M |
| IPO2016 | $ 14M | -$ 346.45K | $ 11M |
Sensus Healthcare Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 9M to $ 27M and net income went from -$ 6M to -$ 7M. Revenue increased in 2 of those 5 years; net income in 2.
Across Sensus Healthcare Inc's full reported history, from 2016 to 2025, revenue grew from $ 14M to $ 27M and net income went from -$ 346.45K to -$ 7M. Revenue increased in 60% of the years measured; net income in 50%.
Sensus Healthcare Inc currently holds a 5-year HDB Score of 3.0 out of 10. How the HDB Score is calculated.
Membership
Explore SRTS with current data
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 5,119 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
Explore other companies
XTL Biopharmaceuticals Ltd ADRXTLB· revenue grew in 60% of years
Avalo Therapeutics IncAVTX· revenue grew in 20% of years- OBIOOrchestra BioMed Holdings Inc.OBIO· revenue grew in 40% of years
Keros Therapeutics IncKROS· revenue grew in 33% of years
Ironwood Pharmaceuticals IncIRWD· revenue grew in 40% of years
